Back to top

Research Daily

Mark Vickery

Top Research Reports for Pfizer, Altria & Newmont Corp.

WMB PFE CEG MO NEM AME

Trades from $3

Monday, June 15, 2026

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Pfizer Inc. (PFE), Altria Group, Inc. (MO) and Newmont Corp. (NEM), as well as two micro-cap stocks, Koil Energy Solutions, Inc. (KLNG) and Stratus Properties Inc. (STRS). These research reports have been hand-picked from roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Ahead of Wall Street

The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.

You can read today's AWS here >>> Peace Agreement Sends Pre-Market Futures Higher

Today's Featured Research Reports

Pfizer’s shares have underperformed the Zacks Large Cap Pharmaceuticals industry over the past year (+7.4% vs. +23.4%). Per the Zacks analyst, the company faces challenges from looming patent expirations on several key drugs, which could weigh on future sales. Its outlook points to limited near-term growth, and the company must navigate competitive pressures while managing the impact of declining legacy product revenues.

However, Pfizer’s non-COVID business is strengthening, supported by strong demand for key medicines, recent product launches, and acquired assets. The company is also rebuilding its oncology and obesity pipeline, which could support longer-term growth and help offset future patent-related headwinds.

(You can read the full research report on Pfizer here >>>)

Altria’s shares have outperformed the Tobacco industry over the past year (+22.3% vs. +6.6%). The Zacks analyst believes that Altria benefits from strong pricing, resilient margins, disciplined cost management and progress in its smoke-free strategy through oral nicotine products and other reduced-risk investments. Its focus on profitability, cash generation and shareholder returns adds to its appeal.

Challenges include ongoing cigarette volume declines, consumer trade-down trends, pressure on Marlboro’s market share, rising competition in smoke-free categories and regulatory restrictions that could limit long-term growth.

(You can read the full research report on Altria here >>>)

Newmonts shares have outperformed the Zacks Mining - Gold industry over the past year (+72.5% vs. +43.9%). The Zacks analyst believes that the company benefits from strong execution, progress on key growth projects and an enhanced asset portfolio following its acquisition of Newcrest. The company is focused on operational efficiency, shareholder returns and stands to gain from a favorable gold-price environment.

Yet rising production costs may pressure margins, while lower gold output could weigh on results. Elevated sustaining capital spending and expectations for higher investment needs have also raised concerns about cash flow generation.

(You can read the full research report on Newmont here >>>)

Koil Energy’s shares have outperformed the Zacks Alternative Energy - Other industry over the past two years (+250.5% vs. +67.7%). The Zacks analyst believes that the company is benefiting from strong backlog growth, steady contract wins and favorable offshore spending trends. Its expanding service business and integrated subsea offerings support more stable revenues and future growth.

However, margin pressure, high operating costs and weak earnings conversion remain concerns. Liquidity risks, working-capital volatility and reliance on fixed-price contracts could also weigh on performance.

(You can read the full research report on Koil Energy here >>>)

Stratus’ shares have underperformed the Zacks Real Estate - Operations industry over the past two years (+13.0% vs. +34.9%). The Zacks analyst believes that the company faces risks from executing asset sales in a challenging real estate market, regulatory uncertainty around key projects, debt-related pressures and reliance on external capital. Weaker multifamily market conditions could also affect timelines and asset values.

Yet, its liquidation strategy provides a clear path to unlocking value. Strong liquidity, expected near-term asset sales and a diversified land portfolio offer flexibility and multiple opportunities for monetization.

(You can read the full research report on Stratus here >>>)

Other noteworthy reports we are featuring today include Interactive Constellation Energy Corp. (CEG), The Williams Companies, Inc. (WMB) and AMETEK, Inc. (AME).

Mark Vickery
Senior Editor

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>

Featured Reports

New Upgrades

New Downgrades